DRI opiate 500ML reagent test kits part number: 0136PSC CD: 6550
Ended Awarded
- Contract number
- N6854625FA083
- Awardee
-
Microgenics Corporation UEI E7WGWEK19Y79
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $8,135
Award facts
- Contract value 100% obligated
- $8,134.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fremont, CA 94538, USA
Award details come from SAM.gov/FPDS.
About this award
Microgenics Corporation's Clinical Diagnostics Division has been awarded a delivery order by the Navy Bureau of Medicine and Surgery valued at $8,134.80 for DRI Opiate 500ML Reagent Test Kits (Part Number 0136PSC). The contract is structured as a firm fixed-price delivery order with no set-aside designation, reflecting Microgenics' competitive position in the federal diagnostic marketplace. The work will be performed in Fremont, California, with an ultimate completion date of December 3, 2025. This award represents a continuation of ongoing supply arrangements under Microgenics' larger indefinite delivery vehicle for DRI Opiate reagent kits valued at $750,435.30, which provides critical diagnostic reagents to support the Department of Defense Drug Demand Reduction Program.
The opiate reagent test kits being delivered support substance abuse testing and screening across military healthcare systems, specifically assisting the Navy Bureau of Medicine and Surgery in identifying controlled substance use within the armed forces. Microgenics, a subsidiary of Thermo Electron Corporation, has established itself as a primary federal contractor for immunoassay diagnostic reagents, holding multiple significant contracts for various toxicology testing products including benzodiazepine, amphetamine, methamphetamine, and opioid detection kits. These contracts are distributed across the Navy, Defense Health Agency, and Veterans Affairs agencies to support comprehensive substance abuse testing and treatment programs throughout the Department of Defense and veterans healthcare networks.
Quick answers
Who was awarded contract N6854625FA083?
N6854625FA083 was awarded to Microgenics Corporation by Bureau of Medicine and Surgery (Department of the Navy) on August 21, 2025.
How much is contract N6854625FA083 worth?
The government has obligated $8,135 on N6854625FA083.
Is contract N6854625FA083 an order under another contract?
Yes. N6854625FA083 is a delivery order under N6264523D5006, an indefinite delivery contract.
Was contract N6854625FA083 competed?
The extent of competition for N6854625FA083 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award